The patent landscape of Chagas disease vaccines indicates major underinvestment in an emerging global health threat
Abstract
Considering the enormous human and economic toll Chagas disease inflicts, investment in R&D of medical innovations such as diagnostics, pharmaceuticals and vaccines remains disproportionately low. The patent landscape of Chagas’ disease vaccine innovation corroborates this unfortunate trend: an alarming paucity of investment which confirms this disease as among the most neglected of the neglected diseases. However, the article then articulates how patent information can also be viewed as a starting point, and indeed springboard, for international collaboration to accelerate vaccine development via a dynamic opening-innovation strategy.
Department
Law
Subject
Patent Law
Publication Date
8-12-2025
Journal Title
Nature Biotechnology
Publisher
Springer Nature
Digital Object Identifier (DOI)
https://doi.org/10.1038/s41587-025-02759-w
Document Type
Article
Recommended Citation
Lily Widdup, Bradley Johnson & Stanley P. Kowalski, The Patent Landscape of Chagas Disease Vaccines Indicates Major Underinvestment in an Emerging Global Health Threat, 43 Nat. Biotechnol 1231 (2025). https://doi.org/10.1038/s41587-025-02759-w